Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avadel Pharmaceuticals PLC

AVDL
Current price
12.96 USD +0.51 USD (+4.10%)
Last closed 12.44 USD
ISIN US05337M1045
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 260 180 864 USD
Yield for 12 month +24.26 %
1Y
3Y
5Y
10Y
15Y
AVDL
21.11.2021 - 28.11.2021

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, 2

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

24.6 USD

P/E ratio

Dividend Yield

Current Year

+27 963 000 USD

Last Year

+1 496 000 USD

Current Quarter

+41 504 000 USD

Last Quarter

+27 178 000 USD

Current Year

+25 351 000 USD

Last Year

-1 493 000 USD

Current Quarter

+38 716 000 USD

Last Quarter

+25 656 000 USD

Key Figures AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -97 231 000 USD
Operating Margin TTM -30.7 %
PE Ratio
Return On Assets TTM -34.45 %
PEG Ratio 0.07
Return On Equity TTM -99.52 %
Wall Street Target Price 24.6 USD
Revenue TTM 95 149 000 USD
Book Value 0.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2674.3 %
Dividend Yield
Gross Profit TTM 16 592 000 USD
Earnings per share -1.09 USD
Diluted Eps TTM -1.09 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -111.64 %

Dividend Analytics AVDL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.9534
Enterprise Value Revenue 12.5169
Price Sales TTM 13.2443
Enterprise Value EBITDA -6.4329
Price Book MRQ 17.9288

Financials AVDL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVDL

For 52 weeks

9.5 USD 19.09 USD
50 Day MA 14.84 USD
Shares Short Prior Month 11 914 676
200 Day MA 15.37 USD
Short Ratio 11.99
Shares Short 11 661 422
Short Percent 13.85 %